Ulf Arne Wiinberg

Mr. Ulf Arne Wiinberg is an Independent Director at MiNK Therapeutics, Inc., an Independent Director at UCB SA, an Independent Director at Alfa Laval AB, a Chairman at Sigrid Therapeutics AB, a Chairman & Chief Executive Officer at Ulf Wiinberg Consult & Invest AB and a President & Chief Executive Officer at X-Vax Technology, Inc. He is on the Board of Directors at AgenTus Therapeutics SA, MiNK Therapeutics, Inc., UCB SA, Alfa Laval AB, European Federation of Pharmaceutical Industries & Assns, International Federation of Pharmaceutical Manufacturers, Lexington Group, Inc., UCB Pharma AB and Wallon Institute for Life Lead Sciences.
Mr. Wiinberg was previously employed as a Chairman & Manager-Human Resources by Trialbee AB, an Independent Director by Agenus, Inc., a Chairman by Hansa Biopharma AB, a Chairman by Avillion LLP, a President & Chief Executive Officer by H.
Lundbeck A/S, a Director-Europe, Middle East & Africa Region by Wyeth Pharmaceuticals LLC, a President-Europe, Middle East & Africa Region by Wyeth LLC, a President by Wyeth Consumer Healthcare, Inc., a Managing Director by John Wyeth & Brother Ltd., a Chairman by Lund Science AB, and a President by Wyeth BioPharma.
He also served on the board at Pharmaceutical Research & Manufacturers of America, Nestle Health Science SA and The European Medicines Agency.